6 New immunosuppressive treatment in transplantation medicine
Baillière's Clinical Gastroenterology, ISSN: 0950-3528, Vol: 8, Issue: 3, Page: 455-464
1994
- 10Citations
- 11Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations10
- Citation Indexes10
- 10
- CrossRef9
- Captures11
- Readers11
- 11
Article Description
Currently, the standard immunosuppressive regimen in organ transplantation is centred around cyclosporin. However, despite the use of this drug, rejection is not uncommon and it is associated with significant side-effects. Novel drugs and regimens have been developed to combat allograft rejection. Although FK506 has a similar mode of action and toxicity profile to cyclosporin, results, particularly in the rescue situation, have been encouraging. Sodium brequinar and rapamycin inhibit lymphocyte proliferation and may be most effective when used in combination with cyclosporin.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/0950352894900310; http://dx.doi.org/10.1016/0950-3528(94)90031-0; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0028133374&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/8000093; https://linkinghub.elsevier.com/retrieve/pii/0950352894900310; http://dx.doi.org/10.1016/0950-3528%2894%2990031-0; https://dx.doi.org/10.1016/0950-3528%2894%2990031-0
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know